Normally, DNA is transcribed, or copied, to RNA and then translated to protein. Reverse transcriptase copies RNA back to DNA. Think of it as a car moving down a one-way street. Normally traffic only moves in one direction. But then, someone from out of town is driving the opposite way! Reverse transcriptase drives the opposite way in molecular processes in cells, converting RNA back to DNA.
Highlights
The global Reverse Transcriptase Enzyme market was valued at US$ 345.4 million in 2022 and is anticipated to reach US$ 501.1 million by 2029, witnessing a CAGR of 6.4% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Thermo Fisher, Promega, Roche, Bio-Rad and Takara Bio are the main producers of Reverse Transcriptase, the top 3 hold nearly 40% of the whole market. North America is the main market, which holds about 40% of the global marketshare.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Reverse Transcriptase Enzyme, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Reverse Transcriptase Enzyme.
The Reverse Transcriptase Enzyme market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Reverse Transcriptase Enzyme market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Reverse Transcriptase Enzyme companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Thermo Fisher Scientific
Bio-Rad
Takara
Biomatik
New England Biolabs
QIAGEN
Promega
AMS Biotechnology
Cell Sciences
Lucigen
Segment by Type
Reverse Transcriptase Enzyme Reagent
Reverse Transcriptase Enzyme Primer
Segment by Application
Hospitals
BIotech Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Reverse Transcriptase Enzyme companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Reverse Transcriptase Enzyme Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Reverse Transcriptase Enzyme Reagent
1.2.3 Reverse Transcriptase Enzyme Primer
1.3 Market by Application
1.3.1 Global Reverse Transcriptase Enzyme Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 BIotech Companies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Reverse Transcriptase Enzyme Market Perspective (2018-2029)
2.2 Reverse Transcriptase Enzyme Growth Trends by Region
2.2.1 Global Reverse Transcriptase Enzyme Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Reverse Transcriptase Enzyme Historic Market Size by Region (2018-2023)
2.2.3 Reverse Transcriptase Enzyme Forecasted Market Size by Region (2024-2029)
2.3 Reverse Transcriptase Enzyme Market Dynamics
2.3.1 Reverse Transcriptase Enzyme Industry Trends
2.3.2 Reverse Transcriptase Enzyme Market Drivers
2.3.3 Reverse Transcriptase Enzyme Market Challenges
2.3.4 Reverse Transcriptase Enzyme Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Reverse Transcriptase Enzyme Players by Revenue
3.1.1 Global Top Reverse Transcriptase Enzyme Players by Revenue (2018-2023)
3.1.2 Global Reverse Transcriptase Enzyme Revenue Market Share by Players (2018-2023)
3.2 Global Reverse Transcriptase Enzyme Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Reverse Transcriptase Enzyme Revenue
3.4 Global Reverse Transcriptase Enzyme Market Concentration Ratio
3.4.1 Global Reverse Transcriptase Enzyme Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Reverse Transcriptase Enzyme Revenue in 2022
3.5 Reverse Transcriptase Enzyme Key Players Head office and Area Served
3.6 Key Players Reverse Transcriptase Enzyme Product Solution and Service
3.7 Date of Enter into Reverse Transcriptase Enzyme Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Reverse Transcriptase Enzyme Breakdown Data by Type
4.1 Global Reverse Transcriptase Enzyme Historic Market Size by Type (2018-2023)
4.2 Global Reverse Transcriptase Enzyme Forecasted Market Size by Type (2024-2029)
5 Reverse Transcriptase Enzyme Breakdown Data by Application
5.1 Global Reverse Transcriptase Enzyme Historic Market Size by Application (2018-2023)
5.2 Global Reverse Transcriptase Enzyme Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Reverse Transcriptase Enzyme Market Size (2018-2029)
6.2 North America Reverse Transcriptase Enzyme Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Reverse Transcriptase Enzyme Market Size by Country (2018-2023)
6.4 North America Reverse Transcriptase Enzyme Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Reverse Transcriptase Enzyme Market Size (2018-2029)
7.2 Europe Reverse Transcriptase Enzyme Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Reverse Transcriptase Enzyme Market Size by Country (2018-2023)
7.4 Europe Reverse Transcriptase Enzyme Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Reverse Transcriptase Enzyme Market Size (2018-2029)
8.2 Asia-Pacific Reverse Transcriptase Enzyme Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Reverse Transcriptase Enzyme Market Size by Region (2018-2023)
8.4 Asia-Pacific Reverse Transcriptase Enzyme Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Reverse Transcriptase Enzyme Market Size (2018-2029)
9.2 Latin America Reverse Transcriptase Enzyme Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Reverse Transcriptase Enzyme Market Size by Country (2018-2023)
9.4 Latin America Reverse Transcriptase Enzyme Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Reverse Transcriptase Enzyme Market Size (2018-2029)
10.2 Middle East & Africa Reverse Transcriptase Enzyme Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Reverse Transcriptase Enzyme Market Size by Country (2018-2023)
10.4 Middle East & Africa Reverse Transcriptase Enzyme Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Reverse Transcriptase Enzyme Introduction
11.1.4 Thermo Fisher Scientific Revenue in Reverse Transcriptase Enzyme Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Bio-Rad
11.2.1 Bio-Rad Company Detail
11.2.2 Bio-Rad Business Overview
11.2.3 Bio-Rad Reverse Transcriptase Enzyme Introduction
11.2.4 Bio-Rad Revenue in Reverse Transcriptase Enzyme Business (2018-2023)
11.2.5 Bio-Rad Recent Development
11.3 Takara
11.3.1 Takara Company Detail
11.3.2 Takara Business Overview
11.3.3 Takara Reverse Transcriptase Enzyme Introduction
11.3.4 Takara Revenue in Reverse Transcriptase Enzyme Business (2018-2023)
11.3.5 Takara Recent Development
11.4 Biomatik
11.4.1 Biomatik Company Detail
11.4.2 Biomatik Business Overview
11.4.3 Biomatik Reverse Transcriptase Enzyme Introduction
11.4.4 Biomatik Revenue in Reverse Transcriptase Enzyme Business (2018-2023)
11.4.5 Biomatik Recent Development
11.5 New England Biolabs
11.5.1 New England Biolabs Company Detail
11.5.2 New England Biolabs Business Overview
11.5.3 New England Biolabs Reverse Transcriptase Enzyme Introduction
11.5.4 New England Biolabs Revenue in Reverse Transcriptase Enzyme Business (2018-2023)
11.5.5 New England Biolabs Recent Development
11.6 QIAGEN
11.6.1 QIAGEN Company Detail
11.6.2 QIAGEN Business Overview
11.6.3 QIAGEN Reverse Transcriptase Enzyme Introduction
11.6.4 QIAGEN Revenue in Reverse Transcriptase Enzyme Business (2018-2023)
11.6.5 QIAGEN Recent Development
11.7 Promega
11.7.1 Promega Company Detail
11.7.2 Promega Business Overview
11.7.3 Promega Reverse Transcriptase Enzyme Introduction
11.7.4 Promega Revenue in Reverse Transcriptase Enzyme Business (2018-2023)
11.7.5 Promega Recent Development
11.8 AMS Biotechnology
11.8.1 AMS Biotechnology Company Detail
11.8.2 AMS Biotechnology Business Overview
11.8.3 AMS Biotechnology Reverse Transcriptase Enzyme Introduction
11.8.4 AMS Biotechnology Revenue in Reverse Transcriptase Enzyme Business (2018-2023)
11.8.5 AMS Biotechnology Recent Development
11.9 Cell Sciences
11.9.1 Cell Sciences Company Detail
11.9.2 Cell Sciences Business Overview
11.9.3 Cell Sciences Reverse Transcriptase Enzyme Introduction
11.9.4 Cell Sciences Revenue in Reverse Transcriptase Enzyme Business (2018-2023)
11.9.5 Cell Sciences Recent Development
11.10 Lucigen
11.10.1 Lucigen Company Detail
11.10.2 Lucigen Business Overview
11.10.3 Lucigen Reverse Transcriptase Enzyme Introduction
11.10.4 Lucigen Revenue in Reverse Transcriptase Enzyme Business (2018-2023)
11.10.5 Lucigen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Thermo Fisher Scientific
Bio-Rad
Takara
Biomatik
New England Biolabs
QIAGEN
Promega
AMS Biotechnology
Cell Sciences
Lucigen
听
听
*If Applicable.
